Adenophora divaricata Franch. & Sav. Attenuates Particulate Matter-Induced Inflammatory Responses in RAW264.7

Ji-Hye Ha1,2, Ba-Wool Lee1, Da-Hye Yi1

  • 1Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup-si 56212, Jeollabuk-do, Republic of Korea.

Cells
|April 27, 2026
PubMed

Insights

Adenophora divaricate (AD) extract reduces lung inflammation caused by particulate matter (PM) by targeting oxidative stress and the TXNIP/NLRP3 inflammasome pathway, suggesting its therapeutic potential.

Area of Science:

  • Environmental Health
  • Pharmacology
  • Immunology

Background:

  • Particulate matter (PM) exposure causes pulmonary inflammation and respiratory diseases through unclear molecular mechanisms.
  • The reactive oxygen species (ROS)-mediated thioredoxin-interacting protein (TXNIP) and NOD-like receptor pyrin domain containing (NLRP3) inflammasome pathway is implicated in PM-induced inflammation.

Purpose of the Study:

  • To investigate the anti-inflammatory mechanisms of Adenophora divaricate (AD) in particulate matter (PM)-induced lung inflammation.
  • To determine if AD modulates the ROS-TXNIP-NLRP3 inflammasome pathway.

Main Methods:

  • Evaluated anti-inflammatory properties of AD methanolic extract in PM-stimulated RAW264.7 cells and PM-exposed mice.
  • Administered PM intranasally to mice and AD or dexamethasone orally for 7 days.
  • Assessed pulmonary inflammation, oxidative stress markers, glutathione content, TXNIP/NLRP3 inflammasome expression, and lung histopathology.

Main Results:

  • AD treatment significantly reduced pulmonary inflammation, inflammatory cell counts, and cytokine levels in bronchoalveolar lavage fluid.
  • AD decreased oxidative stress markers (ROS, TBARS) and increased glutathione content.
  • AD suppressed TXNIP/NLRP3 inflammasome expression and alleviated lung tissue inflammatory responses.

Conclusions:

  • ROS-mediated TXNIP is a key regulator in PM-induced lung inflammation.
  • Adenophora divaricate (AD) exhibits anti-inflammatory effects by modulating the ROS-TXNIP-NLRP3 inflammasome pathway.
  • AD shows potential as a therapeutic agent for pulmonary inflammation.

Related Concept Videos